Amyloidosis Support Groups webinar for ATTR patients in the Pacific Northwest region recorded on March 13, 2021. Muriel Finkel, President of Amyloidosis Support Groups, leads the webinar which features top amyloidosis physicians in Oregon and Washington. The webinar is presented by: Deirdre Mooney, MD, MPH, FACC, Cardiologist at Sacred Heart Medical Center, Providence Health & …
Amyloidosis Support Groups webinar on ATTR amyloidosis from July 23, 2022. Led by ASG President Muriel Finkel, featured speaker Jonathan Wall, PhD, Professor, University of Tennessee Graduate School of Medicine, Knoxville, TN, talks about AT-01 Diagnostic Imaging Agent for Systemic Amyloidosis.
Professor Jonathan Wall of the University of Tennessee presents an update on ATTR amyloid imaging using a peptide for systemic amyloidosis, from ASG’s 12/05/2020 ATTR Webinar.
Presented by the Amyloidosis Speakers Bureau … Learn about wild-type amyloidosis from both an expert clinician and his patient. Listen to world-renowned cardiologist Dr. Mathew S. Maurer of New York-Presbyterian Hospital / Columbia University Medical Center overview wild-type amyloidosis (ATTRwt), followed by one of his patients John Basdavanos as he shares his journey with wild-type …
An Overview of Wild-Type Amyloidosis (ATTRwt): A World-Renowned Expert and His Patient Read More »
A webinar discussion of the epidemiology, clinical, prevention and social aspects of COVID-19 infection in diverse populations.
Amyloidosis Support Groups webinar on ATTR amyloidosis from July 23, 2022. Led by ASG President Muriel Finkel, featured speaker Gustavo Buchele, MD, PhD, Executive Director, Clinical Development, Ionis Pharmaceuticals, talks about AstraZeneca/Ionis TTRansform Update.
This outstanding webcast of Lymphoma & Myeloma 2013, an International Congress on Hematologic Malignancies, includes experts presenting the current issues and clinical trial information in lymphoma, CLL, and multiple myeloma. The chairs of the meeting were Drs. Morton Coleman, John Leonard, Ruben Niesvizsky, and Richard Furman.
Amyloidosis is the depositing of abnormal proteins into the body. Unlike most proteins, amyloid proteins cannot be broken down by the body. In this video Dr. Morie Gertz, a Mayo Clinic hematologist and chair of Mayo’s Department of Medicine, talks about Mayo’s approach to treating this rare condition.
President of Amyloidosis Support Groups, leads the webinar which features top amyloidosis physicians in Oregon and Washington. The webinar is presented by: Edward N. Libby, MD, Hematology/Oncology, Associate Professor, Medical Oncology, University of Washington, Seattle, WA.
Watch and listen to this informative presentation for amyloidosis patients by Dr. Morie Gertz from the Mayo Clinic on March 16, 2015.